Provided by Tiger Fintech (Singapore) Pte. Ltd.

10x Genomics, Inc.

14.30
+1.209.16%
Post-market: 14.490.1900+1.33%19:59 EDT
Volume:3.45M
Turnover:48.25M
Market Cap:1.78B
PE:-20.67
High:14.30
Open:13.16
Low:13.11
Close:13.10
52wk High:24.76
52wk Low:6.78
Shares:124.49M
Float Shares:112.38M
Volume Ratio:1.40
T/O Rate:3.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6917
EPS(LYR):-1.5162
ROE:-11.30%
ROA:-9.45%
PB:2.30
PE(LYR):-9.43

Loading ...

10x Genomics Unveils Xenium Protein, Pioneering Simultaneous RNA and Protein Analysis for Deeper Disease Insights

Reuters
·
Aug 19

J.P. Morgan Remains a Hold on 10x Genomics (TXG)

TIPRANKS
·
Aug 12

Why 10x Genomics (TXG) Is Down 6.0% After Tariff-Driven Q2 Revenue Surge and Guidance Update

Simply Wall St.
·
Aug 09

10x Genomics Is Maintained at Neutral by UBS

Dow Jones
·
Aug 09

10x Genomics (TXG) Gets a Buy from Stifel Nicolaus

TIPRANKS
·
Aug 08

Stock Track | 10x Genomics Plummets 5.08% Despite Strong Q2 Earnings and Analyst Upgrades

Stock Track
·
Aug 08

UBS Adjusts Price Target on 10x Genomics to $13 From $12, Maintains Neutral Rating

MT Newswires Live
·
Aug 08

Deutsche Bank Adjusts 10x Genomics Price Target to $14 From $10, Maintains Hold Rating

MT Newswires Live
·
Aug 08

Stock Track | 10x Genomics Surges 7.81% Pre-Market on Stellar Q2 Results, Acquisition Plans, and Analyst Upgrades

Stock Track
·
Aug 08

10x Genomics Inc : JP Morgan Raises Target Price to $13 From $9

THOMSON REUTERS
·
Aug 08

Stock Track | 10x Genomics Soars 5.47% on Strong Q2 Results, Acquisition News, and Positive Outlook

Stock Track
·
Aug 08

Stock Track | 10x Genomics Soars 5.47% on Strong Q2 Results, Acquisition News, and Positive Outlook

Stock Track
·
Aug 08

10x Genomics Inc. Releases Transcript of Second Quarter 2025 Financial Results Call

Reuters
·
Aug 08

10X Genomics' Q2 revenue beats estimates

Reuters
·
Aug 08

Stock Track | 10x Genomics Soars 5.08% After-Hours on Strong Q2 Results and Acquisition News

Stock Track
·
Aug 08

10x Genomics Q2 EPS $0.28 Beats $(0.36) Estimate, Sales $172.900M Beat $139.408M Estimate

Benzinga
·
Aug 08

10x Genomics - Expects Q3 2025 Revenue to Be in the Range of $140 Million to $144 Million

THOMSON REUTERS
·
Aug 08

10x Genomics Inc - Expects Q3 2025 Revenue Between $140 Mln and $144 Mln

THOMSON REUTERS
·
Aug 08

10x Genomics to Acquire Scale Biosciences

THOMSON REUTERS
·
Aug 08

10x Genomics (TXG) Is Up 6.3% After AI Spatial Biology Collaboration With A*STAR Genome Institute - Has The Bull Case Changed?

Simply Wall St.
·
Jul 23